AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Nexium (esomeprazole) — Worldwide product sales by Year
Nexium (esomeprazole) — Worldwide product sales ($M) ($M)
AstraZeneca Nexium (esomeprazole) — Worldwide product sales: $816M in FY2025, down 5.9% from a year earlier. That is the lowest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Nexium | 816 | (6) | (5) | 67 | (30) | 611 | 3 | 5 | 50 | (18) | (20) | 88 | (26) | (26)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Nexium (esomeprazole) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 816 | -5.9% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 867 | -8.3% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 945 | -26.5% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 1,285 | -3.1% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 1,326 | -11.1% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 1,492 | +0.6% | Form 6-K FY2020Q4 Earnings Release ↗ |
| FY2019 | Dec 31, 2019 | 1,483 | -12.9% | Form 20-F (filed 2020-03-03) ↗ |
| FY2018 | Dec 31, 2018 | 1,702 | -12.8% | Form 20-F (filed 2019-03-05) ↗ |
| FY2017 | Dec 31, 2017 | 1,952 | -3.9% | Form 20-F (filed 2019-03-05) ↗ |
| FY2016 | Dec 31, 2016 | 2,032 | – | Form 20-F (filed 2019-03-05) ↗ |
Breakdown
What makes up nexium (esomeprazole) — Worldwide product sales
- Nexium (esomeprazole) — Worldwide YoY actual (%)-6.0% · FY2025
- Nexium (esomeprazole) — Worldwide YoY CER (%)-5.0% · FY2025
- Nexium (esomeprazole) — US product sales ($M)67 · FY2025
- Nexium (esomeprazole) — Emerging Markets product sales ($M)611 · FY2025
- Nexium (esomeprazole) — Europe product sales ($M)50 · FY2025
- Nexium (esomeprazole) — Established RoW product sales ($M)88 · FY2025
Cite this data
StockData. (2026). AstraZeneca Nexium (esomeprazole) — Worldwide product sales ($M), annual FY2016–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-nexium-world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.